| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $31,941,603 ) (Continued on the next page) |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM138030 | Using directed evolution to study the origins of multicellular development | 001 | 7 | NIH | 5/5/2026 | $454,494 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R61MH138966 | A naturalistic multimodal platform for capturing brain-body interactions in people during physical effort-based decision making | 001 | 2 | NIH | 2/11/2026 | -$111,108 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R00EB033580 | Machine Perception Nanosensor Array Platform to Capture Whole Disease Fingerprints of Early Stage Pancreatic Cancer | 002 | 5 | NIH | 2/19/2026 | $25,386 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R21CA290907 | Advanced 3D auxetic biodegradable implant for large volume breast reconstruction | 000 | 2 | NIH | 12/17/2025 | $228,569 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM156318 | Characterizing extracellular glycoproteins and unraveling their functions | 000 | 2 | NIH | 2/10/2026 | $571,457 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R61MH138966 | A naturalistic multimodal platform for capturing brain-body interactions in people during physical effort-based decision making | 000 | 2 | NIH | 2/9/2026 | $1,111,094 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AR082523 | Damage Modeling and Vascular Imaging Correlation with Implant Induced Skin Necrosis | 001 | 3 | NIH | 5/14/2026 | $26,669 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM162583 | Cellular basis of complex behavior | 000 | 1 | NIH | 5/14/2026 | $407,283 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01CA268125 | Mechanisms underlying spontaneous firing by motoneurons with acute neurotoxicity | 000 | 5 | NIH | 1/29/2026 | $424,391 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | AY2AX000135 | HEAL: HEalthy Ameliorated Lymphatics | 000 | 1 | NIH | 2/18/2026 | $8,975,682 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01GM149693 | Administrative Supplement to Promote Re-Entry in Health-Related Research Careers | 000 | 2 | NIH | 1/23/2026 | $91,964 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01CA266013 | Development of Novel Targeted Therapeutic Agents for Castration Resistant Prostate Cancer | 000 | 5 | NIH | 5/14/2026 | $524,183 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01DC020048 | Discovering novel predictors of minimally verbal outcomes in autism through computational modeling | 000 | 5 | NIH | 5/13/2026 | $456,925 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AR083702 | Bactericidal hydrogels for bone repair | 000 | 3 | NIH | 5/19/2026 | $486,779 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01CA273878 | Breast Cancer Brain Metastasis Therapy by Focused Ultrasound-Guided Control of HER2 CAR T cells | 000 | 4 | NIH | 5/18/2026 | $655,363 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM161177 | Harnessing Biomolecular Simulations to Understand Protein Dynamics and Allostery | 000 | 1 | NIH | 5/19/2026 | $432,850 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM150876 | Disentangling Sugar Signaling in Plants | 000 | 4 | NIH | 5/26/2026 | $381,781 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R37CA239039 | TRANSCRANIAL FUS THERAPY WITH CLOSED-LOOP US IMAGE GUIDANCE AND CIRCULATING | 001 | 7 | NIH | 5/28/2026 | $451,467 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM118039 | Interplay of inherent promiscuity and specificity in protein biochemical function with applications to drug discovery and exome analysis | 002 | 11 | NIH | 5/28/2026 | $488,301 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01CA304559 | In Vivo Engineering of Virus-Specific T Cells for CAR T Cell Therapy Against Multiple Myeloma | 000 | 1 | NIH | 5/28/2026 | $705,899 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AI182322 | Microscale Multiplexed Antibody Fc Profiling and Nanoscale Electronic Detection for Rapid and Scalable Point-of-Care Diagnosis of Tuberculosis | 000 | 3 | NIH | 5/20/2026 | $382,775 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | F32AI200229 | Evolutionary Adaptation of Pseudomonas aeruginosa in Response to CFTR Modulator Therapy in individuals with Cystic Fibrosis | 000 | 1 | NIH | 5/20/2026 | $79,348 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01EY036078 | Functional organization and spatial resolution of attentional feedback from frontal to visual cortex | 000 | 2 | NIH | 4/6/2026 | $465,689 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R00EY032603 | Towards a computationally precise characterization of the human ventral visual pathway | 000 | 5 | NIH | 4/1/2026 | $248,752 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01HL173002 | Interoceptors controlling airway constriction | 000 | 3 | NIH | 4/13/2026 | $463,542 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AG073250 | Influences of Environmental Geometry and Aging on Cognitive Mapping Mechanisms | 000 | 5 | NIH | 4/28/2026 | $436,091 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM153457 | Domesticating and Mapping Interactions of the Human Gastrointestinal Microbiome | 000 | 3 | NIH | 4/10/2026 | $370,744 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01EB038279 | Combined IVUS/FFR microcatheter for guiding complex percutaneous coronary interventions | 000 | 1 | NIH | 3/26/2026 | $603,818 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01HD113598 | Personalized Hip vs Ankle Exoskeleton Assistance with Biofeedback to Enhance Mobility Post-Stroke | 001 | 3 | NIH | 3/26/2026 | $51,320 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01EB034359 | Improved arrhythmia ablation via MR-guided robotic catheterization and multimodal clinician feedback | 000 | 4 | NIH | 3/25/2026 | $634,755 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R33CA309789 | In Vitro Human INtraDuctal (HIND) Model of Early Stage Breast Cancer Progression Heterogeneity | 000 | 1 | NIH | 5/1/2026 | $396,406 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM152245 | Integrative predictive medicine to identify disease causes, develop cures, and optimize patient care | 000 | 3 | NIH | 4/21/2026 | $366,688 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R21TR005579 | Improving Bronchoalveolar Lavage To Enhance Diagnostic Yield Of Pulmonary Complications | 000 | 1 | NIH | 4/28/2026 | $416,231 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM150870 | Molecular analysis of bacterial interactions | 000 | 4 | NIH | 4/21/2026 | $373,752 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AG082039 | Inferring multi-scale dynamics underlying behavior in aging C. elegans | 000 | 4 | NIH | 3/27/2026 | $518,133 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | F31HL174122 | Investigating the Effectiveness and Mechanisms of Lymphaticovenous Anastomoses (LVA) for Lymphedema Treatment: Integrating Computational Modeling with Clinical LVA Insights | 000 | 3 | NIH | 5/12/2026 | $50,114 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R00EB033580 | Machine Perception Nanosensor Array Platform to Capture Whole Disease Fingerprints of Early Stage Pancreatic Cancer | 001 | 5 | NIH | 1/22/2026 | $243,137 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AR082523 | Damage Modeling and Vascular Imaging Correlation with Implant Induced Skin Necrosis | 000 | 3 | NIH | 1/21/2026 | $480,059 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | RF1MH140429 | Multiscale Models for Understanding Multi-Animal Interactions and Intent | 000 | 1 | NIH | 3/9/2026 | $2,596,724 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM138354 | The Biophysical Foundations of Bacterial Biofilm Growth and Survival | 001 | 6 | NIH | 2/26/2026 | $382,507 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R37CA289714 | Engineering ingestible nanosensors for breath-based detection of colorectal cancer | 000 | 2 | NIH | 2/27/2026 | $565,564 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R00AG081564 | Age and sex differences in the immune response to synthetic materials | 001 | 4 | NIH | 3/27/2026 | $243,330 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R35GM145350 | Illuminating Heme Trafficking and Signaling Pathways in Health and Disease | 000 | 5 | NIH | 2/27/2026 | $374,712 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R21AI190999 | Mechanosensing through the B cell antigen receptor | 000 | 1 | NIH | 2/19/2026 | $410,864 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R21AI190856 | Characterization of two virulence-associated S. aureus sRNAs | 000 | 2 | NIH | 12/30/2025 | $196,750 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01HD113598 | Personalized Hip vs Ankle Exoskeleton Assistance with Biofeedback to Enhance Mobility Post-Stroke | 000 | 3 | NIH | 1/19/2026 | $461,879 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | 2601GAATSG | FY2026 (ATSG) AT Act State Grants for Assistive Technology | 1 | 1 | ACL | 3/27/2026 | $472,840 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R01AI195271 | Controlled Delivery of Adjuvanted Multivalent Fusion Peptide Focused HIV Vaccines | 000 | 1 | NIH | 1/28/2026 | $725,241 |
| | 2026 | 2026 | GEORGIA TECH RESEARCH CORP | 926 DALNEY ST NW | ATLANTA | GA | 30318-6395 | FULTON | USA | R61MH138966 | A naturalistic multimodal platform for capturing brain-body interactions in people during physical effort-based decision making | 002 | 2 | NIH | 2/16/2026 | $0 |
|
